Loading...
XKRX
096760
Market cap170mUSD
Jul 10, Last price  
3,905.00KRW
1D
5.40%
1Q
-6.47%
Jan 2017
-56.02%
IPO
12.31%
Name

JW Holdings Corp

Chart & Performance

D1W1MN
XKRX:096760 chart
P/E
4.62
P/S
0.28
EPS
845.56
Div Yield, %
—
Shrs. gr., 5y
-0.58%
Rev. gr., 5y
4.40%
Revenues
969.04b
+9.16%
237,690,310,000529,239,679,000556,675,690,000554,239,674,230516,012,168,270511,945,579,900530,262,876,270573,920,210,970622,617,304,970680,479,987,980683,718,165,770725,365,869,060726,423,996,000781,514,840,000788,936,981,000864,536,431,000928,071,671,000887,710,032,000969,039,677,000
Net income
58.50b
-6.57%
-7,232,724,000-5,165,882,0001,040,783,000-11,563,027,000-32,112,262,000-22,032,155,92017,817,457,410-8,987,986,000181,412,000-8,663,432,00054,021,815,78023,169,194,370-31,636,720,0009,063,719,000-2,778,280,00022,152,012,00019,026,282,00062,617,686,00058,504,803,000
CFO
163.67b
+67.19%
16,241,967,0008,284,997,000-6,940,143,000-1,615,130,760-3,887,889,710861,853,070-54,030,353,410-17,175,940,050-23,975,359,150-29,214,390,35010,511,742,250195,762,386,11098,682,527,000108,622,768,000109,644,020,000104,426,314,000112,317,546,00097,892,442,000163,666,847,000
Dividend
Dec 27, 2024115 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

JW Holdings Corporation, alongside its numerous subsidiaries, is a key player in the manufacturing and commercialization of pharmaceuticals and medical devices. Its operations span South Korea and global markets. The company's diverse offerings include ethical medications, non-prescription consumer health goods, and specialized equipment for IV solutions. Established in 1945, JW Holdings maintains its headquarters in Seoul, South Korea.
URL
http://www.jw-holdings.co.kr
IPO date
Jul 31, 2007
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT